See more : Morguard Corporation (MRCBF) Income Statement Analysis – Financial Results
Complete financial analysis of PepGen Inc. (PEPG) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of PepGen Inc., a leading company in the Biotechnology industry within the Healthcare sector.
- Aviva plc (AVVIY) Income Statement Analysis – Financial Results
- Infomina Berhad (0265.KL) Income Statement Analysis – Financial Results
- The Brink’s Company (BCO) Income Statement Analysis – Financial Results
- Starfleet Innotech, Inc. (SFIO) Income Statement Analysis – Financial Results
- Just Planning Inc. (4287.T) Income Statement Analysis – Financial Results
PepGen Inc. (PEPG)
About PepGen Inc.
PepGen Inc., a clinical-stage biotechnology company, focuses on the development of oligonucleotide therapeutics for use in the treatment of severe neuromuscular and neurologic diseases. The company's lead product candidate is PGN-EDO51, an EDO peptide in Phase I clinical trials to treat individuals with Duchenne muscular dystrophy (DMD). It is also developing PGN-EDODM1, an EDO peptide-conjugated PMO for the treatment of myotonic dystrophy type 1, as well as EDO therapeutic candidates, such as PGN-EDO53, PGN-EDO45, and PGN-EDO44 for the treatment of DMD. The company was founded in 2018 and is headquartered in Cambridge, Massachusetts.
Metric | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|
Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cost of Revenue | 1.18M | 493.00K | 178.00K | 110.00K | 106.00K |
Gross Profit | -1.18M | -493.00K | -178.00K | -110.00K | -106.00K |
Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Research & Development | 66.94M | 54.08M | 19.00M | 1.02M | 620.00K |
General & Administrative | 16.64M | 14.22M | 8.11M | 853.00K | 628.00K |
Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 627.37K |
SG&A | 16.64M | 14.22M | 8.11M | 853.00K | 628.00K |
Other Expenses | 0.00 | 110.00K | -172.00K | -20.00K | 0.00 |
Operating Expenses | 84.77M | 68.30M | 27.11M | 1.88M | 1.25M |
Cost & Expenses | 84.77M | 68.30M | 27.11M | 1.88M | 1.35M |
Interest Income | 6.40M | 2.79M | 0.00 | 8.00K | 6.00K |
Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Depreciation & Amortization | 1.18M | 493.00K | 178.00K | 110.00K | 106.00K |
EBITDA | -83.58M | -67.81M | -26.93M | -1.77M | -1.25M |
EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Operating Income | -84.77M | -68.30M | -27.11M | -1.88M | -1.35M |
Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Total Other Income/Expenses | 6.21M | 2.90M | -172.00K | -12.00K | 8.00K |
Income Before Tax | -78.55M | -65.40M | -27.28M | -1.89M | -1.35M |
Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Income Tax Expense | 73.00K | 3.71M | -58.56K | -8.00K | 0.00 |
Net Income | -78.63M | -69.10M | -27.28M | -1.88M | -1.35M |
Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
EPS | -3.30 | -2.91 | -1.22 | -0.08 | -0.06 |
EPS Diluted | -3.30 | -2.91 | -1.22 | -0.08 | -0.06 |
Weighted Avg Shares Out | 23.80M | 23.71M | 22.39M | 22.39M | 22.39M |
Weighted Avg Shares Out (Dil) | 23.80M | 23.71M | 22.39M | 22.39M | 22.39M |
Levi & Korsinsky Reminds Shareholders of an Investigation into PepGen Inc. (PEPG) Regarding Potential Securities Fraud Allegations
PEPG Investors Can Participate In The PepGen Inc Securities Fraud Investigation With The Schall Law Firm
Levi & Korsinsky Reminds PepGen Investors of the Ongoing Investigation into Potential Violations of Securities Laws – PEPG
Investors who lost money on PepGen Inc. should contact Levi & Korsinsky about an ongoing investigation - PEPG
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
Levi & Korsinsky Announces an Investigation on Behalf of PepGen Inc. (PEPG) Shareholders Who May Have Been Affected by Fraud
PepGen Inc. (PEPG) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
PEPG STOCK ALERT: Levi & Korsinsky Notifies PepGen Inc. Investors of an Ongoing Investigation
PEPG Investors Have Opportunity To Join PepGen Inc Securities Fraud Investigation With The Schall Law Firm
Did PepGen Inc. Mislead Investors? Shareholder Rights Advocates at Levi & Korsinsky Investigate - PEPG
Source: https://incomestatements.info
Category: Stock Reports